key: cord-0031880-xurkajd6
authors: Sookaromdee, Pathum; Wiwanitkit, Viroj
title: COVID-19 vaccination and anti-CD19 CAR-T-induced B-cell aplasia: Correspondence()
date: 2022-05-19
journal: Transplant Cell Ther
DOI: 10.1016/j.jtct.2022.05.024
sha: 1133a0d01a99b75842bf39ffdc8ac87606d9ce49
doc_id: 31880
cord_uid: xurkajd6

nan

B-cell deficit owing to anti-CD19 CAR-T treatment, according to Jarisch et al. [1] . We agree that patients with anti-CD19 CAR-T-induced B-cell aplasia may or may not have a different immunological response to COVID-19 vaccination. The current research can provide some evidence regarding immunological parameters following vaccination. However, it's important to be aware of the likelihood of asymptomatic COVID-19, which is a prevalent clinical issue [2] . There's a chance the participants in this study had pre-vaccination or post-vaccination asymptomatic COVID-19, and the immunological markers they measured were misinterpreted.

None

Immune responses to SARS-CoV-2 vaccination in young patients with anti-CD19 CAR-Tinduced B-cell aplasia. Transplant Cell Ther

Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period